24th Jul 2015 08:32
LONDON (Alliance News) - Beximco Pharmaceuticals Ltd on Friday expressed confidence in achieving its expected sales, and financial and operational targets for its full year.
For the half year to end-June the company posted a posted a pretax profit of GBP8.3 million, up from GBP5.5 million a year before, as net sales rose to GBP51.5 million from GBP40.2 million. Bexminco reports in the Bangladesh taka, and its sterling results are translated at 122.25 taka to the pound in the current year and 132.44 taka in the previous year.
The generic pharmaceutical products and pharmaceutical ingredients company said it delivered a solid performance across all of its financial and operational areas, seeing 15.4% growth in its domestic business in Bangladesh, and 64% sales growth in its export business.
The company received accreditation from the US Food and Drug Administration, following a successful inspection of its oral solid dosage facility at Tongi.
"Looking ahead, we have good visibility on our order book and remain confident of achieving our expected sales and financial and operational targets for the full year," said Managing Director Nazmul Hassan in a statement.
Shares in Beximco are trading up 5.2% at 18.15 pence Friday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Beximco Pharma